Firm at a glance
Arlington Capital Partners is a platform private equity firm headquartered in Washington, D.C., with approximately $14 billion in committed capital as of mid-2026 [S1].
What they buy
The firm’s portfolio demonstrates a concentration in aerospace and defense businesses, government services and technology contractors, and healthcare companies, per its public investment roster [S2]. Arlington appears to pursue platform acquisitions across these sectors, with recent activity showing both new platform investments and add-on transactions to existing portfolio companies [S3]. The firm closed Fund VII in October 2025, indicating active deployment of fresh capital [S3].
Portfolio
Aerospace & Defense
Highwater (platform, 2026), FMI Industries (platform, 2025), AV (platform, 2025), GRVTY (platform, 2024), Kinetic Engine Systems (platform, 2023), and Keel (platform, 2023) [S2].
Government Services & Technology
ENERCON (platform, 2025), Neumo (platform, 2023), and IDS (platform, 2023) [S2].
Healthcare
CBSET (platform, 2025), Cordica Medical (platform, 2024), and Afton Scientific (platform, 2024) [S2].
Business Services & Software
Exostar (platform, 2023) [S2].
Recent activity (last 24 months)
* Tyto Athene acquisition (July 2026) [S3]
* Highwater acquisition (July 2026) [S3]
* AMP United add-on (July 2026) [S3]
* Riverpoint Medical exit (June 2026) [S3]
* Enercon acquisition (April 2026) [S3]
* Eptec Defence acquisition (March 2026) [S3]
* Forged Solutions Group exit (March 2026) [S3]
* Striping Technology add-on (January 2026) [S3]
* Pond & Company acquisition (January 2026) [S3]
* Tex-Tech Industries exit (January 2026) [S3]
* Stellant Systems exit (December 2025) [S3]
* Highway Barricades & Services add-on (December 2025) [S3]
* Fund VII close (October 2025) [S3]
* Group W add-on (October 2025) [S3]
* CBSET acquisition (October 2025) [S3]
* TAG3 Engineering add-on (September 2025) [S3]
* ImmunoPrecise Antibodies Europe add-on (August 2025) [S3]
* Duke Empirical add-on (July 2025) [S3]
* stackArmor add-on (May 2025) [S3]
* Intrepid add-on (March 2025) [S3]
* Proximity Advisory Services add-on (March 2025) [S3]
* TEAM Technologies acquisition (November 2024) [S3]
* BlueHalo exit (November 2024) [S3]
How this firm fits a seller
Arlington’s transaction history shows both platform acquisitions and active add-on strategies, suggesting the firm may suit sellers in aerospace, defense, government contracting, and healthcare who are comfortable with either platform or bolt-on positioning [S2][S3]. The firm’s recent exit activity, including four portfolio company sales in the trailing 24 months, indicates an active realization program [S3]. Businesses serving government end markets or operating in regulated healthcare sectors may find sector alignment with Arlington’s demonstrated investment focus [S2].
Sources
[S1] https://arlingtoncap.com (as of 2026-07-08)
[S2] https://arlingtoncap.com/investments/ (as of 2026-07-08)
[S3] https://arlingtoncap.com/news/ (as of 2026-07-08)
Frequently asked questions
Does Arlington Capital Partners buy Aerospace & Defense businesses?
Yes, aerospace and defense represents a core investment sector for the firm, with six platform companies in this category as of mid-2026, including Highwater, FMI Industries, AV, GRVTY, Kinetic Engine Systems, and Keel [S2]. Recent acquisitions include Highwater in July 2026 and Eptec Defence in March 2026 [S3].
What companies has Arlington Capital Partners acquired recently?
Recent platform acquisitions include Tyto Athene and Highwater in July 2026, Enercon in April 2026, and Pond & Company in January 2026, per the firm’s news disclosures [S3]. The firm also completed CBSET in October 2025 and TEAM Technologies in November 2024 [S3].
Where is Arlington Capital Partners based and how big is the firm?
The firm is based in Washington, D.C., and reports approximately $14 billion in committed capital as of mid-2026 [S1]. Arlington closed its seventh fund in October 2025, indicating ongoing fundraising and deployment activity [S3].
Is Arlington Capital Partners still actively acquiring?
Yes, the firm completed multiple acquisitions in 2026, including Tyto Athene and Highwater in July, Enercon in April, and Eptec Defence in March, demonstrating active deal execution [S3]. The October 2025 close of Fund VII further supports continued acquisition activity [S3].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.